RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Capstone Therapeutics Stock

Capstone Therapeutics P/E 2024

Capstone Therapeutics P/E

0

Ticker

CAPS

ISIN

US14068E2081

WKN

A2PRWA

As of Dec 24, 2024, Capstone Therapeutics's P/E ratio was 0, a -100% change from the -0.01 P/E ratio recorded in the previous year.

The Capstone Therapeutics P/E history

Capstone Therapeutics Aktienanalyse

What does Capstone Therapeutics do?

Capstone Therapeutics Corp. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for unmet medical needs. The company was founded in 1987 and is headquartered in Tempe, Arizona. It began as a research project at Arizona State University, eventually leading to the founding of the company. Capstone Therapeutics utilizes its technology platform in peptide chemistry, cell biology, and pharmacology to develop therapies for diseases with limited treatment options. Its core business includes developing medications for neurodegenerative diseases like Alzheimer's and oncological diseases with no effective treatment options. The company collaborates with other industry leaders in biotechnology and holds a strong intellectual property position. Capstone Therapeutics aims to improve the lives of individuals with serious illnesses through its innovative products and strategic approach. Capstone Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Capstone Therapeutics's P/E Ratio

The Price to Earnings (P/E) Ratio of Capstone Therapeutics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Capstone Therapeutics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Capstone Therapeutics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Capstone Therapeutics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Capstone Therapeutics stock

What is the price-to-earnings ratio of Capstone Therapeutics?

The price-earnings ratio of Capstone Therapeutics is currently 0.

How has the price-earnings ratio of Capstone Therapeutics changed compared to last year?

The price-to-earnings ratio of Capstone Therapeutics has increased by -100% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Capstone Therapeutics high compared to other companies?

Yes, the price-to-earnings ratio of Capstone Therapeutics is high compared to other companies.

How does an increase in the price-earnings ratio of Capstone Therapeutics affect the company?

An increase in the price-earnings ratio of Capstone Therapeutics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Capstone Therapeutics affect the company?

A decrease in the price-earnings ratio of Capstone Therapeutics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Capstone Therapeutics?

Some factors that influence the price-earnings ratio of Capstone Therapeutics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Capstone Therapeutics pay?

Over the past 12 months, Capstone Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Capstone Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Capstone Therapeutics?

The current dividend yield of Capstone Therapeutics is .

When does Capstone Therapeutics pay dividends?

Capstone Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Capstone Therapeutics?

Capstone Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Capstone Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Capstone Therapeutics located?

Capstone Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Capstone Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Capstone Therapeutics from 12/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.

When did Capstone Therapeutics pay the last dividend?

The last dividend was paid out on 12/24/2024.

What was the dividend of Capstone Therapeutics in the year 2023?

In the year 2023, Capstone Therapeutics distributed 0 USD as dividends.

In which currency does Capstone Therapeutics pay out the dividend?

The dividends of Capstone Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Capstone Therapeutics

Our stock analysis for Capstone Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Capstone Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.